松软
发表于 2025-3-23 12:30:30
The Pipeline Challenge: How to Organize Innovation, innovation scissors.” The nature of the pipeline permits increasingly sophisticated portfolio analysis of drugs in development, offering pharma companies managerial options in managing individual drug candidates based on accessible competencies, risks, and expected benefits.
tooth-decay
发表于 2025-3-23 15:36:49
The Open Innovation Challenge: How to Partner for Innovation,nge the traditional, established inhouse-only R&D paradigm. An outlook of the rise of corporate venture funds in the pharma industry illustrates how important the management and valuation of intellectual property is in the life science industry.
Cursory
发表于 2025-3-23 19:57:59
The Internationalization Challenge: Where to Access Innovation,ngle of foreign R&D investors and from the perspective of indigenous Chinese players. Given the significant cost pressures in mature markets, reverse innovation in healthcare has drawn considerable attention by local governments.
阻塞
发表于 2025-3-23 22:13:42
Book 2018Latest edition edition was expanded to reflect the latest updates in open and collaborative innovation, the greater strategic importance of venture capital and early-stage investments, and the new range of emerging technologies now being put to use in pharmaceutical innovation..
连系
发表于 2025-3-24 06:08:39
http://reply.papertrans.cn/59/5825/582420/582420_15.png
起皱纹
发表于 2025-3-24 07:23:05
http://reply.papertrans.cn/59/5825/582420/582420_16.png
入会
发表于 2025-3-24 11:08:01
Innovation: Key to Success in the Pharmaceutical Industry, pharma companies, the cost structures for pharma innovation, and the nature of the productivity gap. We describe the blockbuster imperative and the pervasive concerns about risk and safety in pharma R&D, and conclude with a brief outlook on the main themes to be discussed in the remainder of the book.
ACRID
发表于 2025-3-24 16:40:33
http://reply.papertrans.cn/59/5825/582420/582420_18.png
LEVER
发表于 2025-3-24 22:26:55
http://reply.papertrans.cn/59/5825/582420/582420_19.png
indenture
发表于 2025-3-25 01:13:53
The Make-or-Buy Challenge: How to In- and Outsource Innovation, are discussed in detail and illustrated with cases from industry. We conclude with an example of how a breakthrough innovation can best be commercialized by a small pharma company using those make-or-buy options.